Market Cap 1.20B
Revenue (ttm) 308.05M
Net Income (ttm) -95.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -31.02%
Debt to Equity Ratio 0.15
Volume 1,738,200
Avg Vol 1,629,510
Day's Range N/A - N/A
Shares Out 56.92M
Stochastic %K 26%
Beta 0.87
Analysts Sell
Price Target $30.20

Company Profile

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower u...

Industry: Medical Devices
Sector: Healthcare
Phone: 650 232 7200
Address:
150 Baytech Drive, San Jose, United States
DrMunch
DrMunch Jul. 2 at 4:19 PM
$PRCT This would be a nice acquisition for one of the big boys. Two billion could get you in the urology business overnight.
0 · Reply
Nasdaq_Frontier
Nasdaq_Frontier Jun. 28 at 10:21 PM
Our not missing the robotics bull run: Healthcare Robotics $ISRG Intuitive Surgical $SYK Stryker $MDT Medtronic $PRCT PROCEPT Healthcare robotics may be one of the easiest robotics themes to monetize. ISRG has already proven the robotic surgery model. SYK and MDT continue to expand robotic-assisted procedures through their powerful medical ecosystems, while PRCT is rapidly gaining share in minimally invasive urology. Unlike many robotics companies still in the concept stage, healthcare robotics already has real demand, recurring revenue, and a long growth runway. With aging populations and the rise of precision medicine, penetration rates still have plenty of room to grow. Which company do you think becomes the biggest winner in healthcare robotics over the next decade?
0 · Reply
scwillia
scwillia Jun. 24 at 2:25 PM
$PRCT Evercore initiation - $15 bear case, $30 base-case, $38 bull case. 25% downside risk, c.100% upside in bull-case.
0 · Reply
Startersorder
Startersorder Jun. 24 at 12:23 PM
$PRCT Evercore initiates a BUY on PRCT.
0 · Reply
lpInvestor
lpInvestor Jun. 24 at 11:58 AM
0 · Reply
scwillia
scwillia Jun. 24 at 10:30 AM
$PRCT Evercore initiation TODAY with BUY recommendation and $30 PT
0 · Reply
Wisenheimer
Wisenheimer Jun. 23 at 2:51 PM
$PRCT stock is expensive regardless
2 · Reply
Muddymac
Muddymac Jun. 22 at 5:12 PM
$PRCT Rough road ahead for the next couple quarters.
1 · Reply
Startersorder
Startersorder Jun. 18 at 10:40 AM
$PRCT The price move recently makes no sense. Analysts who pumped the price in 2024 (it was too frothy) doing the same thing by revising the price lower when PRCT is doing a great job. The downgrade by Leerink, citing PAE as a headwind, is in direct opposition to what Larry Wood (CEO) stated at the last E/C. “I don’t think PAE is a headwind for us at all. I think PAE is a big red herring. It’s a procedure that really does not get performed in any volume in Europe. And the reason it doesn’t get performed is because it doesn’t get paid for because it’s not a very good procedure.” If you believe Larry PRCT is oversold and looks cheap. PRCT made a change reporting handpiece sales V procedures, so there was a shortfall on revenue. It could have stuck with the old system and hit its numbers. If it hits in Q2, then it will fly. It is the best BPH procedure out there and with the no of machines in the field when it starts P- Cancer (1000+) the revenue will bump up. Same machine does both.
1 · Reply
Major_High_Finance_Stud
Major_High_Finance_Stud Jun. 15 at 7:22 PM
$PRCT added a lil. Disconnect between analysts & practitioners is too big to ignore. Turning into a "go lower so i can buy more" long term play for me.
0 · Reply
Latest News on PRCT
Procept BioRobotics downgraded to Hold from Buy at Truist

2026-07-02T20:10:24.000Z - 1 day ago

Procept BioRobotics downgraded to Hold from Buy at Truist


PROCEPT BioRobotics Slides: Conference presentation

Jun 29, 2026, 7:00 AM EDT - 5 days ago

PROCEPT BioRobotics Slides: Conference presentation


Procept BioRobotics reports Q1 EPS (56c), consensus (55c)

2026-04-29T22:30:21.000Z - 2 months ago

Procept BioRobotics reports Q1 EPS (56c), consensus (55c)


PROCEPT BioRobotics Earnings Call Transcript: Q1 2026

Apr 29, 2026, 4:30 PM EDT - 2 months ago

PROCEPT BioRobotics Earnings Call Transcript: Q1 2026


PROCEPT BioRobotics Earnings release: Q1 2026

Apr 29, 2026, 4:30 PM EDT - 2 months ago

PROCEPT BioRobotics Earnings release: Q1 2026


PROCEPT BioRobotics Quarterly report: Q1 2026

Apr 29, 2026, 4:30 PM EDT - 2 months ago

PROCEPT BioRobotics Quarterly report: Q1 2026


PROCEPT BioRobotics Reports First Quarter 2026 Financial Results

Apr 29, 2026, 4:03 PM EDT - 2 months ago

PROCEPT BioRobotics Reports First Quarter 2026 Financial Results


PROCEPT BioRobotics Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 2 months ago

PROCEPT BioRobotics Proxy statement: Proxy filing


PROCEPT BioRobotics Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 2 months ago

PROCEPT BioRobotics Proxy statement: Proxy filing


Procept BioRobotics initiated with a Neutral at Baird

2026-03-06T10:20:49.000Z - 4 months ago

Procept BioRobotics initiated with a Neutral at Baird


Procept BioRobotics initiated with a Neutral at Baird

2026-03-05T21:27:27.000Z - 4 months ago

Procept BioRobotics initiated with a Neutral at Baird


Procept BioRobotics price target lowered to $30 from $62 at UBS

2026-03-02T14:13:04.000Z - 4 months ago

Procept BioRobotics price target lowered to $30 from $62 at UBS


Procept BioRobotics sees FY26 revenue growth 27%-33%

2026-02-26T13:03:17.000Z - 4 months ago

Procept BioRobotics sees FY26 revenue growth 27%-33%


PROCEPT BioRobotics Transcript: Investor Day 2026

Feb 26, 2026, 8:00 AM EST - 4 months ago

PROCEPT BioRobotics Transcript: Investor Day 2026


PROCEPT BioRobotics Slides: FY 2026

Feb 26, 2026, 8:00 AM EST - 4 months ago

PROCEPT BioRobotics Slides: FY 2026


PROCEPT BioRobotics Earnings Call Transcript: Q4 2025

Feb 25, 2026, 4:30 PM EST - 4 months ago

PROCEPT BioRobotics Earnings Call Transcript: Q4 2025


PROCEPT BioRobotics Annual report: Q4 2025

Feb 25, 2026, 4:30 PM EST - 4 months ago

PROCEPT BioRobotics Annual report: Q4 2025


PROCEPT BioRobotics Earnings release: Q4 2025

Feb 25, 2026, 4:30 PM EST - 4 months ago

PROCEPT BioRobotics Earnings release: Q4 2025


PROCEPT BioRobotics Earnings Call Transcript: Q3 2025

Nov 4, 2025, 4:30 PM EST - 8 months ago

PROCEPT BioRobotics Earnings Call Transcript: Q3 2025


PROCEPT BioRobotics Quarterly report: Q3 2025

Nov 4, 2025, 4:30 PM EST - 8 months ago

PROCEPT BioRobotics Quarterly report: Q3 2025


PROCEPT BioRobotics Earnings release: Q3 2025

Nov 4, 2025, 4:30 PM EST - 8 months ago

PROCEPT BioRobotics Earnings release: Q3 2025


PROCEPT BioRobotics Slides: Q3 2025

Nov 4, 2025, 4:30 PM EST - 8 months ago

PROCEPT BioRobotics Slides: Q3 2025


PROCEPT BioRobotics Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 11 months ago

PROCEPT BioRobotics Earnings Call Transcript: Q2 2025


PROCEPT BioRobotics Quarterly report: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 11 months ago

PROCEPT BioRobotics Quarterly report: Q2 2025


PROCEPT BioRobotics Earnings release: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 11 months ago

PROCEPT BioRobotics Earnings release: Q2 2025


PROCEPT BioRobotics Transcript: Status Update

Apr 25, 2025, 11:00 AM EDT - 1 year ago

PROCEPT BioRobotics Transcript: Status Update


PROCEPT BioRobotics Slides: Status Update

Apr 25, 2025, 11:00 AM EDT - 1 year ago

PROCEPT BioRobotics Slides: Status Update


PROCEPT BioRobotics Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

PROCEPT BioRobotics Proxy statement: Proxy Filing


PROCEPT BioRobotics Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

PROCEPT BioRobotics Proxy statement: Proxy Filing


PROCEPT BioRobotics Slides: Investor Presentation

Apr 25, 2025, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics Slides: Investor Presentation


PROCEPT BioRobotics Earnings Call Transcript: Q1 2025

Apr 24, 2025, 8:00 AM EDT - 1 year ago

PROCEPT BioRobotics Earnings Call Transcript: Q1 2025


PROCEPT BioRobotics Quarterly report: Q1 2025

Apr 24, 2025, 8:00 AM EDT - 1 year ago

PROCEPT BioRobotics Quarterly report: Q1 2025


PROCEPT BioRobotics Earnings release: Q1 2025

Apr 24, 2025, 8:00 AM EDT - 1 year ago

PROCEPT BioRobotics Earnings release: Q1 2025


PROCEPT BioRobotics Slides: Investor Presentation

Apr 24, 2025, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics Slides: Investor Presentation


PROCEPT BioRobotics Earnings Call Transcript: Q4 2024

Feb 25, 2025, 4:30 PM EST - 1 year ago

PROCEPT BioRobotics Earnings Call Transcript: Q4 2024


PROCEPT BioRobotics Annual report: Q4 2024

Feb 25, 2025, 4:30 PM EST - 1 year ago

PROCEPT BioRobotics Annual report: Q4 2024


PROCEPT BioRobotics Earnings release: Q4 2024

Feb 25, 2025, 4:30 PM EST - 1 year ago

PROCEPT BioRobotics Earnings release: Q4 2024


PROCEPT BioRobotics Slides: Q4 2024

Feb 25, 2025, 4:30 PM EST - 1 year ago

PROCEPT BioRobotics Slides: Q4 2024


PROCEPT BioRobotics Earnings Call Transcript: Q3 2024

Oct 28, 2024, 8:00 AM EDT - 1 year ago

PROCEPT BioRobotics Earnings Call Transcript: Q3 2024


PROCEPT BioRobotics Quarterly report: Q3 2024

Oct 28, 2024, 8:00 AM EDT - 1 year ago

PROCEPT BioRobotics Quarterly report: Q3 2024


PROCEPT BioRobotics Earnings release: Q3 2024

Oct 28, 2024, 8:00 AM EDT - 1 year ago

PROCEPT BioRobotics Earnings release: Q3 2024


PROCEPT BioRobotics Slides: Q3 2024

Oct 28, 2024, 8:00 AM EDT - 1 year ago

PROCEPT BioRobotics Slides: Q3 2024


PROCEPT BioRobotics Transcript: Status Update

Aug 21, 2024, 8:00 AM EDT - 2 years ago

PROCEPT BioRobotics Transcript: Status Update


PROCEPT BioRobotics Press release: Status Update

Aug 21, 2024, 8:00 AM EDT - 2 years ago

PROCEPT BioRobotics Press release: Status Update


PROCEPT BioRobotics Earnings Call Transcript: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

PROCEPT BioRobotics Earnings Call Transcript: Q2 2024


PROCEPT BioRobotics Quarterly report: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

PROCEPT BioRobotics Quarterly report: Q2 2024


PROCEPT BioRobotics Earnings release: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

PROCEPT BioRobotics Earnings release: Q2 2024


PROCEPT BioRobotics Slides: Q2 2024

Aug 1, 2024, 4:30 PM EDT - 2 years ago

PROCEPT BioRobotics Slides: Q2 2024


DrMunch
DrMunch Jul. 2 at 4:19 PM
$PRCT This would be a nice acquisition for one of the big boys. Two billion could get you in the urology business overnight.
0 · Reply
Nasdaq_Frontier
Nasdaq_Frontier Jun. 28 at 10:21 PM
Our not missing the robotics bull run: Healthcare Robotics $ISRG Intuitive Surgical $SYK Stryker $MDT Medtronic $PRCT PROCEPT Healthcare robotics may be one of the easiest robotics themes to monetize. ISRG has already proven the robotic surgery model. SYK and MDT continue to expand robotic-assisted procedures through their powerful medical ecosystems, while PRCT is rapidly gaining share in minimally invasive urology. Unlike many robotics companies still in the concept stage, healthcare robotics already has real demand, recurring revenue, and a long growth runway. With aging populations and the rise of precision medicine, penetration rates still have plenty of room to grow. Which company do you think becomes the biggest winner in healthcare robotics over the next decade?
0 · Reply
scwillia
scwillia Jun. 24 at 2:25 PM
$PRCT Evercore initiation - $15 bear case, $30 base-case, $38 bull case. 25% downside risk, c.100% upside in bull-case.
0 · Reply
Startersorder
Startersorder Jun. 24 at 12:23 PM
$PRCT Evercore initiates a BUY on PRCT.
0 · Reply
lpInvestor
lpInvestor Jun. 24 at 11:58 AM
0 · Reply
scwillia
scwillia Jun. 24 at 10:30 AM
$PRCT Evercore initiation TODAY with BUY recommendation and $30 PT
0 · Reply
Wisenheimer
Wisenheimer Jun. 23 at 2:51 PM
$PRCT stock is expensive regardless
2 · Reply
Muddymac
Muddymac Jun. 22 at 5:12 PM
$PRCT Rough road ahead for the next couple quarters.
1 · Reply
Startersorder
Startersorder Jun. 18 at 10:40 AM
$PRCT The price move recently makes no sense. Analysts who pumped the price in 2024 (it was too frothy) doing the same thing by revising the price lower when PRCT is doing a great job. The downgrade by Leerink, citing PAE as a headwind, is in direct opposition to what Larry Wood (CEO) stated at the last E/C. “I don’t think PAE is a headwind for us at all. I think PAE is a big red herring. It’s a procedure that really does not get performed in any volume in Europe. And the reason it doesn’t get performed is because it doesn’t get paid for because it’s not a very good procedure.” If you believe Larry PRCT is oversold and looks cheap. PRCT made a change reporting handpiece sales V procedures, so there was a shortfall on revenue. It could have stuck with the old system and hit its numbers. If it hits in Q2, then it will fly. It is the best BPH procedure out there and with the no of machines in the field when it starts P- Cancer (1000+) the revenue will bump up. Same machine does both.
1 · Reply
Major_High_Finance_Stud
Major_High_Finance_Stud Jun. 15 at 7:22 PM
$PRCT added a lil. Disconnect between analysts & practitioners is too big to ignore. Turning into a "go lower so i can buy more" long term play for me.
0 · Reply
alexpitti
alexpitti Jun. 15 at 5:49 PM
Shocking decline $PRCT
0 · Reply
playground14
playground14 Jun. 15 at 5:04 PM
0 · Reply
Jabrontinoooooooo
Jabrontinoooooooo Jun. 15 at 2:44 PM
$PRCT @THE_Money_Banana_Genius when we adding moar king?
1 · Reply
aristocks
aristocks Jun. 15 at 12:59 PM
Because not all companies are created equal… My bad list.. aka crap 💩 list: $S $PRCT $BCRX
0 · Reply
Magic8BallResponse
Magic8BallResponse Jun. 12 at 6:36 PM
$PRCT Folks on the sidelines until cancer visibility... jmho
0 · Reply
blakeh89
blakeh89 Jun. 11 at 1:22 PM
$PRCT https://x.com/marketsday/status/2065046846238790020?s=46&t=ZupQZ8ikbkjfuwbs9CukUQ Some idiot down grades it from $31 to $29 and price nukes 6% to $27? lol
0 · Reply
JasonCO
JasonCO Jun. 10 at 6:09 PM
$PRCT don’t even think about tapping $30. No possible
0 · Reply
Modiadi
Modiadi Jun. 9 at 6:24 PM
$PRCT break 29.7 and 32$ and we see aggressive buying.
0 · Reply
howardlindzon
howardlindzon Jun. 8 at 3:42 PM
$PRCT basing...robots for urology surgery...hmm
1 · Reply
ZRadly
ZRadly Jun. 8 at 2:23 PM
$PRCT 🙂
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Jun. 2 at 12:05 AM
$PRCT @JasonCO ??
1 · Reply
il_perito
il_perito Jun. 1 at 3:42 PM
$PRCT What are the news?
0 · Reply